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Smooth muscle cell (SMC) proliferation is a common response to 
vascular stress and a central feature in vascular diseases, such as 
atherosclerosis, restenosis and allograft vasculopathy. Among the 
variety of signaling pathways implicated in stress-induced SMC 
proliferation, oxidative stress and the sphingolipid pathway play a 
critical role. The molecular link between reactive oxygen species 
and the activation of the sphingolipid pathway is only partly 
understood. This study was carried out to investigate the role of 
the sphingolipid pathway in the mitogenic signaling elicited by of 
H2O2 in SMC.
Low concentration of H2O2 triggered SMC proliferation through a 
signaling pathway involving the activation of MMP2 metalloprotease, 
and neutral sphingomyelinase-2 (nSMase2). Inhibition of MMP2 by 
Batimastat, a broad-speci city MMP inhibitor, or the defect of 
MMP2-/- ( broblasts from MMP2 de cient mice) blocked the H2O2-
induced activation of nSMase2 and DNA synthesis, suggesting that 
all this enzyme activity is dependent on MMP2 activation. The 
genetic defect of nSMase2 ( broblasts from nSMase2-de cient fro/
fro mice), and the use of nSMase2 speci c siRNA did not inhibit the 
H2O2-induced activation of MMP2, but blocked the DNA synthesis.
In conclusion, these data shed light on a novel mechanism of 
stress-induced mitogenic response to low concentration of H2O2, 
involving the sequential action of MMP2 and nSMase2 with possible 
consequences under conditions leading to increased oxidative 
stress in the vascular wall.
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Objectives — Smooth muscle cell (SMC) proliferation is a major 
feature in atherosclerosis, since it contributes to the formation 
of the  brous cap, thus to plaque stability, but also to arterial 
stenosis and post-angioplasty restenosis. Among the various 
mitogenic signaling pathways involved in SMC proliferation, the 
mTOR pathway regulates both the cell cycle and cell growth. 
Resveratrol, a polyphenolic compound from grapes and red wine, 
has potential anti-atherogenic and anti-cancer properties. This 
work was designed to investigate the activation of the mTOR 
pathway by the proatherogenic oxidized LDL (oxLDL) in SMC, and 
the potential inhibitory effect of resveratrol.
Results — mTOR and its downstream target p70S6 kinase are 
phosphorylated and activated by mitogenic concentrations of 
oxLDL (50mug/ml), and are involved in SMC proliferation, as 
assessed by the inhibitory effect of the mTOR inhibitor rapamycin. 
The activation of mTOR signaling by oxLDL, requires the upstream 
activation of PI3K and Akt, as assessed by the inhibitory effect of 
the PI3K inhibitor Ly294002 on mTOR activation and DNA synthesis. 
Resveratrol blocked the oxLDL-induced phosphorylation and 
activation of the PI3K/Akt/mTOR/p70S6K pathway and strongly 
inhibited both the DNA synthesis and proliferation of SMC. This 
activity is independent of the anti-oxidant effect and of AMPK 
activation by resveratrol.
Conclusion — These data indicate that the mTOR pathway is 
activated by oxLDL via PI3K/PDK1/Akt, and is required for SMC 
proliferation. Resveratrol blocks speci cally this pathway, thereby 
inhibiting oxLDL-induced SMC proliferation. These data highlight a 
new property for resveratrol that could contribute to the general 
anti-atherogenic properties of this polyphenol.
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Les microparticules cellulaires jouent un rôle clé dans le contrôle 
de l’homéostasie vasculaire. S’il est clairement établi qu’elles 
représentent des vecteurs d’information biologique à multiples 
facettes (coagulation, in ammation, protéolyse), leur implication 
dans le contrôle de la génération de plasmine n’a pas été 
documentée à ce jour. 
Notre travail a montré que les microparticules endothéliales 
(MPE) représentent des surfaces biologiques capables d’activer 
le plasminogène en plasmine grâce à l’expression du système de 
l’urokinase (uPA) et de son récepteur (uPAR). Cette activité est 
saturable et spéci que comme l’indique l’inhibition de la formation 
de plasmine par l’acide ε-aminocaproïque et la carboxypeptidase 
B. Elle est ampli ée par la capacité des MPE à lier de l’uPA exogène 
sur l’uPAR. Une partie de la plasmine formée, reste liée à la 
surface des MPE, ce qui protège cette enzyme de ses inhibiteurs 
physiologiques. De manière intéressante, cette activité varie 
en fonction de l’origine anatomique des cellules endothéliales, 
traduisant ainsi l’expression hétérogène du système uPA/uPAR le 
long de l’arbre vasculaire.
La génération de plasmine induite par les MPE module la capacité 
des progéniteurs à former des tubes vasculaires dans une matrice 
